Use of glitazones in cardiac patients: a case for B-type natriuretic peptide monitoring?

Several cases of congestive heart failure in patients with a history of cardiac disease treated with glitazones have been reported. Monitoring B-type natriuretic peptide levels in this population may be beneficial.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2004-03, Vol.93 (5), p.600-602
Hauptverfasser:	El Muayed, Malek, Lavis, Victor R., Safi, Hazim J., Fuentes, Francisco
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Cardiovascular disease Diabetes Complications Diabetes Mellitus - drug therapy Drug therapy Heart failure Heart Failure - blood Heart Failure - complications Humans Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Natriuretic Peptide, Brain - blood Peptides Thiazolidinediones - pharmacology Thiazolidinediones - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Several cases of congestive heart failure in patients with a history of cardiac disease treated with glitazones have been reported. Monitoring B-type natriuretic peptide levels in this population may be beneficial.
ISSN:	0002-9149 1879-1913
DOI:	10.1016/j.amjcard.2003.11.025